Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 14(1): 8081, 2024 04 06.
Article in English | MEDLINE | ID: mdl-38582923

ABSTRACT

Astaxanthin, a versatile C40 carotenoid prized for its applications in food, cosmetics, and health, is a bright red pigment with powerful antioxidant properties. To enhance astaxanthin production in Corynebacterium glutamicum, we employed rational pathway engineering strategies, focused on improving precursor availability and optimizing terminal oxy-functionalized C40 carotenoid biosynthesis. Our efforts resulted in an increased astaxanthin precursor supply with 1.5-fold higher ß-carotene production with strain BETA6 (18 mg g-1 CDW). Further advancements in astaxanthin production were made by fine-tuning the expression of the ß-carotene hydroxylase gene crtZ and ß-carotene ketolase gene crtW, yielding a nearly fivefold increase in astaxanthin (strain ASTA**), with astaxanthin constituting 72% of total carotenoids. ASTA** was successfully transferred to a 2 L fed-batch fermentation with an enhanced titer of 103 mg L-1 astaxanthin with a volumetric productivity of 1.5 mg L-1 h-1. Based on this strain a pathway expansion was achieved towards glycosylated C40 carotenoids under heterologous expression of the glycosyltransferase gene crtX. To the best of our knowledge, this is the first time astaxanthin-ß-D-diglucoside was produced with C. glutamicum achieving high titers of microbial C40 glucosides of 39 mg L-1. This study showcases the potential of pathway engineering to unlock novel C40 carotenoid variants for diverse industrial applications.


Subject(s)
Carotenoids , Corynebacterium glutamicum , Carotenoids/metabolism , Corynebacterium glutamicum/genetics , Corynebacterium glutamicum/metabolism , Xanthophylls/metabolism , beta Carotene/metabolism , Metabolic Engineering/methods
2.
J Agric Food Chem ; 71(20): 7765-7776, 2023 May 24.
Article in English | MEDLINE | ID: mdl-37162369

ABSTRACT

Lycopene ß-cyclase (EC 5.5.1.19) is one of the key enzymes in the biosynthesis of ß-carotene and derived carotenoids. It catalyzes isomerase reactions to form ß-carotene from lycopene by ß-cyclization of both of its ψ-ends. Lycopene ß-cyclases are widespread in nature. We systematically analyzed the phylogeny of lycopene ß-cyclases from all kingdoms of life and predicted their transmembrane structures. To this end, a collection of previously characterized lycopene ß-cyclase polypeptide sequences served as bait sequences to identify their closest homologues in a range of bacteria, archaea, fungi, algae, and plant species. Furthermore, a DeepTMHMM scan was applied to search for the presence of transmembrane domains. A phylogenetic tree suggests at least five distinct clades, and the DeepTMHMM scan revealed that lycopene ß-cyclases are a group of structurally different proteins: membrane-bound and cytosolic enzymes. Representative lycopene ß-cyclases were screened in the lycopene-overproducing Corynebacterium glutamicum strain for ß-carotene and astaxanthin production. This systematic screening facilitates the identification of new enzymes for carotenoid production. Higher astaxanthin production and less reduction of total carotenoids were achieved with the cytosolic lycopene ß-cyclase CrtL from Synechococcus elongatus and the membrane-bound heterodimeric lycopene ß-cyclase CrtYcd from Brevibacterium linens.


Subject(s)
Corynebacterium glutamicum , Intramolecular Lyases , Intramolecular Lyases/genetics , beta Carotene/chemistry , Phylogeny , Lycopene
3.
Methods Enzymol ; 671: 383-419, 2022.
Article in English | MEDLINE | ID: mdl-35878987

ABSTRACT

Metabolic engineering for the development of microbial production strains, such as carotenoid overproducing bacteria, has a long history in industrial biotechnology. In contrast to classical strain development that mostly relies on the generation and screening of mutant libraries, rational strain development relies on the identification of a genetic target that has to be engineered in order to overcome metabolic bottlenecks facilitating the production of the desired valuable compounds. In this work, two synthetic biology approaches, namely, a CRISPRi-library and a genetically encoded biosensor, are demonstrated as tools for metabolic engineering purposes with a focus on carotenoid biosynthesis in C. glutamicum. The methods presented here gave insights into carotenoid biosynthesis and facilitated development of new metabolic engineering strategies. The use of a genetically encoded biosensor, the screening of a CRISPRi-library, and their combination can be transferred to study a wide range of organisms and target compounds.


Subject(s)
Biosensing Techniques , Corynebacterium glutamicum , Carotenoids/metabolism , Corynebacterium glutamicum/genetics , Corynebacterium glutamicum/metabolism , Gene Expression , Metabolic Engineering/methods , Synthetic Biology/methods
4.
Microorganisms ; 9(4)2021 Mar 24.
Article in English | MEDLINE | ID: mdl-33805131

ABSTRACT

Corynebacterium glutamicum is a prominent production host for various value-added compounds in white biotechnology. Gene repression by dCas9/clustered regularly interspaced short palindromic repeats (CRISPR) interference (CRISPRi) allows for the identification of target genes for metabolic engineering. In this study, a CRISPRi-based library for the repression of 74 genes of C. glutamicum was constructed. The chosen genes included genes encoding enzymes of glycolysis, the pentose phosphate pathway, and the tricarboxylic acid cycle, regulatory genes, as well as genes of the methylerythritol phosphate and carotenoid biosynthesis pathways. As expected, CRISPRi-mediated repression of the carotenogenesis repressor gene crtR resulted in increased pigmentation and cellular content of the native carotenoid pigment decaprenoxanthin. CRISPRi screening identified 14 genes that affected decaprenoxanthin biosynthesis when repressed. Carotenoid biosynthesis was significantly decreased upon CRISPRi-mediated repression of 11 of these genes, while repression of 3 genes was beneficial for decaprenoxanthin production. Largely, but not in all cases, deletion of selected genes identified in the CRISPRi screen confirmed the pigmentation phenotypes obtained by CRISPRi. Notably, deletion of pgi as well as of gapA improved decaprenoxanthin levels 43-fold and 9-fold, respectively. The scope of the designed library to identify metabolic engineering targets, transfer of gene repression to stable gene deletion, and limitations of the approach were discussed.

SELECTION OF CITATIONS
SEARCH DETAIL
...